News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
AI/ML Innovations Inc. announces FDA submission for MaxYield™ platform, a cloud-based AI-powered technology for clearer ECG signal interpretation, with stock option grant. Aims for breakthrough solutions in digital health -